We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · June 01, 2021

Intensive vs Standard BP Control With MRI Biomarkers of Alzheimer Disease

JAMA Neurology

 

Additional Info

JAMA Neurology
Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial
JAMA Neurol 2021 May 01;78(5)568-577, IM Nasrallah, SA Gaussoin, R Pomponio, S Dolui, G Erus, CB Wright, LJ Launer, JA Detre, DA Wolk, C Davatzikos, JD Williamson, NM Pajewski, RN Bryan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading